109 related articles for article (PubMed ID: 2289220)
1. Treatment of asthma with tulobuterol or albuterol in school-age children.
Le Bourgeois M; de Blic J; Chauvin JP; Scheinmann P; Paupe J
Clin Ther; 1990; 12(6):513-9. PubMed ID: 2289220
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of tulobuterol aerosol in childhood asthma.
Sienra-Monge JJ; Graham-Zapata LF; Del Rio-Navarro BE
J Int Med Res; 1990; 18(6):483-8. PubMed ID: 2292330
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary function tests in asthmatic children in treatment with tulobuterol].
Pérez-Martini L; Blanco RA; Heffner G; Ordóñez-Comparini R
Bol Med Hosp Infant Mex; 1989 Apr; 46(4):241-5. PubMed ID: 2719810
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
8. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Kobayashi Y; Yasuba H; Kudou M; Kita H
J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
[TBL] [Abstract][Full Text] [Related]
10. Isoetharine versus albuterol for acute asthma: greater immediate effect, but more side effects.
Shrestha M; Gourlay S; Robertson S; Bidadi K; Wainscott M; Hayes J
Am J Med; 1996 Mar; 100(3):323-7. PubMed ID: 8629678
[TBL] [Abstract][Full Text] [Related]
11. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
13. Safety of salmeterol in the maintenance treatment of asthma.
Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
[TBL] [Abstract][Full Text] [Related]
14. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
Pearlman DS
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
Lin Q; Liu QH; Bao YX
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
[TBL] [Abstract][Full Text] [Related]
16. Open cross-over comparison of tulobuterol and fenoterol in asthmatic adult patients.
Sanchez J; Rivero A; Dal-Re R; Azanza JR
Int J Clin Pharmacol Res; 1988; 8(4):279-85. PubMed ID: 3182119
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
Germouty J
Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bronchodilator effect of tulobuterol and salbutamol aerosols in patients with asthma.
Patel KR
Br J Clin Pharmacol; 1985 Dec; 20(6):717-8. PubMed ID: 4092004
[No Abstract] [Full Text] [Related]
19. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.
Patel KR
Br J Clin Pharmacol; 1986 Feb; 21(2):234-7. PubMed ID: 3513811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
